Similar Articles
291 Inhibition of apoptosis in the management of nonalcoholic fatty liver disease
292 Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment
293 Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?
294 Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers
295 Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease
296 Current viewpoints on platelet contribution to inflammation
297 PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease
298 Inflammation- and stress-related signaling pathways in hepatocarcinogenesis
299 Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease
300 Peroxisomes, oxidative stress, and inflammation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA